algaecytes limited

Live EstablishedSmallHigh

algaecytes limited Company Information

Share ALGAECYTES LIMITED

Company Number

07264317

Shareholders

kcp nominees ltd

nazir bhatt bashir

View All

Group Structure

View All

Industry

Other research and experimental development on natural sciences and engineering

 

Registered Address

camburgh house, 27, new dover road, canterbury, kent, CT1 3DN

algaecytes limited Estimated Valuation

£2.2m

Pomanda estimates the enterprise value of ALGAECYTES LIMITED at £2.2m based on a Turnover of £1.7m and 1.29x industry multiple (adjusted for size and gross margin).

algaecytes limited Estimated Valuation

£0

Pomanda estimates the enterprise value of ALGAECYTES LIMITED at £0 based on an EBITDA of £-1.4m and a 5.89x industry multiple (adjusted for size and gross margin).

algaecytes limited Estimated Valuation

£8m

Pomanda estimates the enterprise value of ALGAECYTES LIMITED at £8m based on Net Assets of £3.9m and 2.03x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Algaecytes Limited Overview

Algaecytes Limited is a live company located in canterbury, CT1 3DN with a Companies House number of 07264317. It operates in the other research and experimental development on natural sciences and engineering sector, SIC Code 72190. Founded in May 2010, it's largest shareholder is kcp nominees ltd with a 50.5% stake. Algaecytes Limited is a established, small sized company, Pomanda has estimated its turnover at £1.7m with high growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Algaecytes Limited Health Check

Pomanda's financial health check has awarded Algaecytes Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 3 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating4.5out of 5
positive_score

4 Strong

positive_score

3 Regular

positive_score

3 Weak

size

Size

annual sales of £1.7m, make it smaller than the average company (£4.2m)

£1.7m - Algaecytes Limited

£4.2m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 26%, show it is growing at a faster rate (7.9%)

26% - Algaecytes Limited

7.9% - Industry AVG

production

Production

with a gross margin of 48.7%, this company has a comparable cost of product (48.7%)

48.7% - Algaecytes Limited

48.7% - Industry AVG

profitability

Profitability

an operating margin of -82.6% make it less profitable than the average company (1.1%)

-82.6% - Algaecytes Limited

1.1% - Industry AVG

employees

Employees

with 13 employees, this is below the industry average (44)

13 - Algaecytes Limited

44 - Industry AVG

paystructure

Pay Structure

on an average salary of £65.5k, the company has an equivalent pay structure (£65.5k)

£65.5k - Algaecytes Limited

£65.5k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £132k, this is equally as efficient (£129.6k)

£132k - Algaecytes Limited

£129.6k - Industry AVG

debtordays

Debtor Days

There is insufficient data available for this Key Performance Indicator!

- - Algaecytes Limited

- - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 176 days, this is slower than average (44 days)

176 days - Algaecytes Limited

44 days - Industry AVG

stockdays

Stock Days

There is insufficient data available for this Key Performance Indicator!

- - Algaecytes Limited

- - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 104 weeks, this is more cash available to meet short term requirements (36 weeks)

104 weeks - Algaecytes Limited

36 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 17.9%, this is a lower level of debt than the average (39.1%)

17.9% - Algaecytes Limited

39.1% - Industry AVG

ALGAECYTES LIMITED financials

EXPORTms excel logo

Algaecytes Limited's latest turnover from August 2024 is estimated at £1.7 million and the company has net assets of £3.9 million. According to their latest financial statements, Algaecytes Limited has 13 employees and maintains cash reserves of £1.2 million as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Aug 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012May 2012May 2011
Turnover1,716,3871,594,502928,025864,354710,4071,583,63800000044,15968,3083,180
Other Income Or Grants000000000000000
Cost Of Sales880,778844,267492,144467,635393,499842,67600000024,75938,4981,694
Gross Profit835,610750,235435,880396,719316,908740,96100000019,40029,8101,486
Admin Expenses2,254,1562,848,8072,708,3482,211,7461,554,4452,044,510900,7811,616,967645,010551,064336,027442,75440,14449,42435,985
Operating Profit-1,418,546-2,098,572-2,272,468-1,815,027-1,237,537-1,303,549-900,781-1,616,967-645,010-551,064-336,027-442,754-20,744-19,614-34,499
Interest Payable45,65055,59450,02732,23829,49015,248000000000
Interest Receivable40,32828,47939,4852,1416335400000010331
Pre-Tax Profit-1,423,868-2,125,686-2,283,010-1,845,125-1,266,964-1,318,443-1,074,302-1,758,791-742,640-709,175-537,796-459,302-20,734-19,581-34,498
Tax000000174,860132,97672,712126,302169,0720000
Profit After Tax-1,423,868-2,125,686-2,283,010-1,845,125-1,266,964-1,318,443-899,442-1,625,815-669,928-582,873-368,724-459,302-20,734-19,581-34,498
Dividends Paid000000000000000
Retained Profit-1,423,868-2,125,686-2,283,010-1,845,125-1,266,964-1,318,443-899,442-1,625,815-669,928-582,873-368,724-459,302-20,734-19,581-34,498
Employee Costs851,500960,463767,154733,014591,680809,729597,029563,429472,17952,12749,87847,48047,19146,47845,619
Number Of Employees131512121014121212111111
EBITDA*-1,369,232-2,021,146-2,193,167-1,734,101-1,158,587-1,227,849-817,714-1,201,392-619,070-524,306-310,765-423,713-19,870-18,245-33,281

* Earnings Before Interest, Tax, Depreciation and Amortisation

Aug 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012May 2012May 2011
Tangible Assets873,587914,453977,9521,094,529458,771491,475536,404571,437404,881262,141265,366271,9619521,1662,333
Intangible Assets109,636118,084137,939150,243162,373163,541167,688165,783117,96991,70253,39527,3353,6703,7883,990
Investments & Other2,185,5951,840,952901,598901,5981000000000000
Debtors (Due After 1 year)000000000000000
Total Fixed Assets3,168,8182,873,4892,017,4892,146,370621,244655,016704,092737,220522,850353,843318,761299,2964,6224,9546,323
Stock & work in progress000000000000000
Trade Debtors0097978700000004,8209,74540
Group Debtors000000000000000
Misc Debtors437,448526,8121,773,380852,044253,989477,674456,794267,235253,947174,108148,36831,981000
Cash1,183,965429,153655,7721,600,534112,13414,34380,176448,298514,480232,46244,0117,2883,40512,501520
misc current assets000000000000000
total current assets1,621,413955,9652,429,2492,452,675366,210492,017536,970715,533768,427406,570192,37939,2698,22522,246560
total assets4,790,2313,829,4544,446,7384,599,045987,4541,147,0331,241,0621,452,7531,291,277760,413511,140338,56512,84727,2006,883
Bank overdraft110,000110,00085,00010,0003,3330000000000
Bank loan000000000000000
Trade Creditors 425,332237,034336,784303,970230,123344,292336,175297,55433,109170,428205,06975,59310,4638,9052,000
Group/Directors Accounts000000001,3581,3581,3585,758015,75813,765
other short term finances000000000000000
hp & lease commitments000000000000000
other current liabilities52,58833,50243,234504,796400,600197,82599,06392,261267,81714,57194,22949,740000
total current liabilities587,920380,536465,018818,766634,056542,117435,238389,815302,284186,357300,656131,09110,46324,66315,765
loans268,333341,667451,666506,535511,761451,800019,051327,255500,000500,000510,000000
hp & lease commitments000000000000000
Accruals and Deferred Income000000000000000
other liabilities00000000027,25527,25571,25537,25536,25525,255
provisions00000047,60343,9910000000
total long term liabilities268,333341,667451,666506,535511,761451,80047,60363,042327,255527,255527,255581,25537,25536,25525,255
total liabilities856,253722,203916,6841,325,3011,145,817993,917482,841452,857629,539713,612827,911712,34647,71860,91841,020
net assets3,933,9783,107,2513,530,0543,273,744-158,363153,116758,221999,896661,73846,801-316,771-373,781-34,871-33,718-34,137
total shareholders funds3,933,9783,107,2513,530,0543,273,744-158,363153,116758,221999,896661,73846,801-316,771-373,781-34,871-33,718-34,137
Aug 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012May 2012May 2011
Operating Activities
Operating Profit-1,418,546-2,098,572-2,272,468-1,815,027-1,237,537-1,303,549-900,781-1,616,967-645,010-551,064-336,027-442,754-20,744-19,614-34,499
Depreciation40,86664,75366,64368,28965,94265,04474,468409,14025,36326,50225,03618,8187561,1671,167
Amortisation8,44812,67312,65812,63713,00810,6568,5996,43557725622622311820251
Tax000000174,860132,97672,712126,302169,0720000
Stock000000000000000
Debtors-89,364-1,246,665921,336598,065-223,59820,880189,55913,28879,83925,740116,38727,1614,7809,70540
Creditors188,298-99,75032,81473,847-114,1698,11738,621264,445-137,319-34,641129,47665,1308,4636,9052,000
Accruals and Deferred Income19,086-9,732-461,562104,196202,77598,7626,802-175,556253,246-79,65844,48949,740000
Deferred Taxes & Provisions00000-47,6033,61243,9910000000
Cash flow from operations-1,072,484-883,963-3,543,251-2,154,123-846,383-1,189,453-783,378-948,824-510,270-538,043-84,115-336,004-16,187-21,045-31,321
Investing Activities
capital expenditure05,92849,580-704,554-45,078-26,624-49,939-629,945-194,947-61,840-44,727-313,7158270-7,541
Change in Investments344,643939,3540901,4981000000000000
cash flow from investments-344,643-933,42649,580-1,606,052-45,178-26,624-49,939-629,945-194,947-61,840-44,727-313,7158270-7,541
Financing Activities
Bank loans000000000000000
Group/Directors Accounts0000000-1,35800-4,4005,758-13,7651,99313,765
Other Short Term Loans 000000000000000
Long term loans-73,334-109,999-54,869-5,22659,961451,800-19,051-308,204-172,7450-10,000510,000000
Hire Purchase and Lease Commitments000000000000000
other long term liabilities00000000-27,2550-44,00034,00012,00011,00025,255
share issue2,250,5951,702,8832,539,3205,277,232955,485713,338657,7671,963,9731,284,865946,445425,734120,39220,00020,000361
interest-5,322-27,115-10,542-30,097-29,427-14,89400000010331
cash flow from financing2,171,9391,565,7692,473,9095,241,909986,0191,150,244638,7161,654,4111,084,865946,445367,334670,15018,24533,02639,382
cash and cash equivalents
cash754,812-226,619-944,7621,488,40097,791-65,833-368,122-66,182282,018188,45136,7233,8832,88511,981520
overdraft025,00075,0006,6673,3330000000000
change in cash754,812-251,619-1,019,7621,481,73394,458-65,833-368,122-66,182282,018188,45136,7233,8832,88511,981520

algaecytes limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for algaecytes limited. Get real-time insights into algaecytes limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Algaecytes Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for algaecytes limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in CT1 area or any other competitors across 12 key performance metrics.

algaecytes limited Ownership

ALGAECYTES LIMITED group structure

Algaecytes Limited has 1 subsidiary company.

Ultimate parent company

ALGAECYTES LIMITED

07264317

1 subsidiary

ALGAECYTES LIMITED Shareholders

kcp nominees ltd 50.55%
nazir bhatt bashir 9.92%
christopher graeme every 7.54%
clear blue horizons llc 6.93%
james gerard o'shea 6.33%
kcp nominees (dbc - bbi acount) limited 2.68%
john charles dodd 2.64%
miroslav vosatka 2.64%
wcs nominees limited 2.27%
christopher tawney 1.87%

algaecytes limited directors

Algaecytes Limited currently has 3 directors. The longest serving directors include Mr Andrew Cosentino (Apr 2013) and Mr Ian Warwick (Jun 2015).

officercountryagestartendrole
Mr Andrew CosentinoUnited Kingdom70 years Apr 2013- Director
Mr Ian WarwickUnited Kingdom65 years Jun 2015- Director
Mr Ian WarwickEngland65 years Jun 2015- Director

P&L

August 2024

turnover

1.7m

+8%

operating profit

-1.4m

0%

gross margin

48.7%

+3.47%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

August 2024

net assets

3.9m

+0.27%

total assets

4.8m

+0.25%

cash

1.2m

+1.76%

net assets

Total assets minus all liabilities

algaecytes limited company details

company number

07264317

Type

Private limited with Share Capital

industry

72190 - Other research and experimental development on natural sciences and engineering

incorporation date

May 2010

age

15

incorporated

UK

ultimate parent company

None

accounts

Total Exemption Full

last accounts submitted

August 2024

previous names

N/A

accountant

-

auditor

-

address

camburgh house, 27, new dover road, canterbury, kent, CT1 3DN

Bank

-

Legal Advisor

-

algaecytes limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to algaecytes limited.

algaecytes limited Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for ALGAECYTES LIMITED. This can take several minutes, an email will notify you when this has completed.

algaecytes limited Companies House Filings - See Documents

datedescriptionview/download